Cargando…

Research Progress of Exosome-Loaded miRNA in Osteosarcoma

Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Peng, Lu, Yubao, Cai, Zongyan, Yu, Tianci, Kang, Yuchen, Zhang, Yu, Wang, Xulong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859673/
https://www.ncbi.nlm.nih.gov/pubmed/35179996
http://dx.doi.org/10.1177/10732748221076683
_version_ 1784654514487296000
author Yao, Peng
Lu, Yubao
Cai, Zongyan
Yu, Tianci
Kang, Yuchen
Zhang, Yu
Wang, Xulong
author_facet Yao, Peng
Lu, Yubao
Cai, Zongyan
Yu, Tianci
Kang, Yuchen
Zhang, Yu
Wang, Xulong
author_sort Yao, Peng
collection PubMed
description Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as diagnostic tools, and they play an important role in the occurrence and chemotherapy resistance of osteosarcoma. Therefore, providing a new method for the treatment of osteosarcoma is the key to solving this problem. To systematically summarize the research status of exoskeleton drug-loaded miRNA in osteosarcoma, we identified and evaluated 208 studies and found that exosome-carrying miRNA can be used as an index for the diagnosis and prognosis of osteosarcoma and share a certain relationship with chemosensitivity. In addition, exosomes can also be used as a carrier of genetic drugs able to regulate the progression of osteosarcoma. Based on the above findings, we propose suggestions for the future development of this field, aiming to bring new ideas for the early diagnosis and treatment of osteosarcoma.
format Online
Article
Text
id pubmed-8859673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-88596732022-02-22 Research Progress of Exosome-Loaded miRNA in Osteosarcoma Yao, Peng Lu, Yubao Cai, Zongyan Yu, Tianci Kang, Yuchen Zhang, Yu Wang, Xulong Cancer Control Review Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as diagnostic tools, and they play an important role in the occurrence and chemotherapy resistance of osteosarcoma. Therefore, providing a new method for the treatment of osteosarcoma is the key to solving this problem. To systematically summarize the research status of exoskeleton drug-loaded miRNA in osteosarcoma, we identified and evaluated 208 studies and found that exosome-carrying miRNA can be used as an index for the diagnosis and prognosis of osteosarcoma and share a certain relationship with chemosensitivity. In addition, exosomes can also be used as a carrier of genetic drugs able to regulate the progression of osteosarcoma. Based on the above findings, we propose suggestions for the future development of this field, aiming to bring new ideas for the early diagnosis and treatment of osteosarcoma. SAGE Publications 2022-02-18 /pmc/articles/PMC8859673/ /pubmed/35179996 http://dx.doi.org/10.1177/10732748221076683 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Yao, Peng
Lu, Yubao
Cai, Zongyan
Yu, Tianci
Kang, Yuchen
Zhang, Yu
Wang, Xulong
Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title_full Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title_fullStr Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title_full_unstemmed Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title_short Research Progress of Exosome-Loaded miRNA in Osteosarcoma
title_sort research progress of exosome-loaded mirna in osteosarcoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859673/
https://www.ncbi.nlm.nih.gov/pubmed/35179996
http://dx.doi.org/10.1177/10732748221076683
work_keys_str_mv AT yaopeng researchprogressofexosomeloadedmirnainosteosarcoma
AT luyubao researchprogressofexosomeloadedmirnainosteosarcoma
AT caizongyan researchprogressofexosomeloadedmirnainosteosarcoma
AT yutianci researchprogressofexosomeloadedmirnainosteosarcoma
AT kangyuchen researchprogressofexosomeloadedmirnainosteosarcoma
AT zhangyu researchprogressofexosomeloadedmirnainosteosarcoma
AT wangxulong researchprogressofexosomeloadedmirnainosteosarcoma